Common Contracts
18 similar Underwriting Agreement contracts by 60 Degrees Pharmaceuticals, Inc., BullFrog AI Holdings, Inc., Golden Bull LTD, others
BULLFROG AI HOLDINGS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • February 6th, 2024 • BullFrog AI Holdings, Inc. • Pharmaceutical preparations • New York
BULLFROG AI HOLDINGS, INC., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters,” or each, an “Underwriter”), for whom WallachBeth Capital, LLC is acting as Representative (the “Representative”), an aggregate of 1,507,139 shares (each, a “Firm Share” and in aggregate, the “Firm Shares”) of the Company’s common stock, $0.00001 par value per share (the “Common Stock”) (or pre-funded warrants (each, a “Firm Pre-Funded Warrant,” and in the aggregate, the “Firm Pre-Funded Warrants”) to purchase one share of Common Stock (the “Firm Pre-Funded Warrant Shares”) at an exercise price of $0.001 per share of Common Stock until such time as the Pre- Funded Warrant is exercised in full, subject to adjustment as provided in the Pre-Funded Warrant in lieu thereof), and an aggregate of 1,507,139 warrants (each, a “Firm Warrant,” and in the aggregate, the “Firm Warrants”)
UNDERWRITING AGREEMENT 5,260,901 Units, Each Consisting of One Share of Common Stock and One Warrant to Purchase One Share of Common Stock; and 999,076 Pre- Funded Units, Each Consisting of One Pre-Funded Warrant to Purchase One Share of Common Stock...Underwriting Agreement • February 2nd, 2024 • 60 Degrees Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
An aggregate of 5,260,901 Units (the “Firm Units”), each Firm Unit consisting of: (i) one share of the Company’s common stock, $0.0001 par value per share (the “Common Shares”); and (ii) one non-tradeable warrant to purchase one share of Common Stock (the “Non-Tradeable Warrants”); and
BULLFROG AI HOLDINGS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • January 29th, 2024 • BullFrog AI Holdings, Inc. • Pharmaceutical preparations • New York
BULLFROG AI HOLDINGS, INC., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters,” or each, an “Underwriter”), for whom WallachBeth Capital, LLC is acting as Representative (the “Representative”), an aggregate of [ ] shares (each, a “Firm Share” and in aggregate, the “Firm Shares”) of the Company’s common stock, $0.00001 par value per share (the “Common Stock”), an aggregate of [ ] pre-funded warrants (each, a “Firm Pre-Funded Warrant,” and in the aggregate, the “Firm Pre-Funded Warrants”) to purchase one share of Common Stock (the “Firm Pre-Funded Warrant Shares”) at an exercise price of $[ ] until such time as the Pre-Funded Warrant is exercised in full, subject to adjustment as provided in the Pre-Funded Warrant, and an aggregate of [ ] warrants (each, a “Firm Warrant,” and in the aggregate, the “Firm Warrants”) to purchase one share of Common Stock (th
UNDERWRITING AGREEMENT 1,415,095 Units, Each Consisting of One Share of Common Stock, One Warrant to Purchase One Share of Common Stock, and One Non-tradeable Warrant to Purchase One Share of Common StockUnderwriting Agreement • July 17th, 2023 • 60 Degrees Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
In addition, the Company shall pay the Representative an aggregate cash discount equal to eight percent (8%) of the aggregate sales price of securities sold in the Offering plus one and one-half percent (1.5%) of the aggregate sales price of securities sold in the Offering. In addition, the Company shall issue to the Representative that number of warrants equal to six percent (6%) of the number of securities of common stock sold in the Offering.
UNDERWRITING AGREEMENT [●] Units, Each Consisting of One Share of Common Stock, One Warrant to Purchase One Share of Common Stock, and One Non-tradeable Warrant to Purchase One Share of Common StockUnderwriting Agreement • June 8th, 2023 • 60 Degrees Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
In addition, the Company shall pay the Representative an aggregate cash discount equal to eight percent (8%) of the aggregate sales price of securities sold in the Offering plus one and one-half percent (1.5%) of the aggregate sales price of securities sold in the Offering. In addition, the Company shall issue to the Representative that number of warrants equal to six percent (6%) of the number of securities of common stock sold in the Offering.
UNDERWRITING AGREEMENT [●] Units, Each Consisting of One Share of Common Stock, One Warrant to Purchase One Share of Common Stock, and One Non-tradeable Warrant to Purchase One Share of Common StockUnderwriting Agreement • June 1st, 2023 • 60 Degrees Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
In addition, the Company shall pay the Representative an aggregate cash discount equal to eight percent (8%) of the aggregate sales price of securities sold in the Offering plus one and one-half percent (1.5%) of the aggregate sales price of securities sold in the Offering. In addition, the Company shall issue to the Representative that number of warrants equal to six percent (6%) of the number of securities of common stock sold in the Offering. In the event the Company engages the Representative in a private offering, the Company shall issue to the Representative that number of warrants equal to ten percent (10%) of the number of securities sold in such private offering.
UNDERWRITING AGREEMENT [●] Units, Each Consisting of One Share of Common Stock, One Warrant to Purchase One Share of Common Stock, and One Non-tradeable Warrant to Purchase One Share of Common StockUnderwriting Agreement • April 28th, 2023 • 60 Degrees Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
The Company has prepared and filed with the Securities and Exchange Commission (the “Commission”) a registration statement covering the Securities (as defined in Section 4(f) hereof) on Form S-1 (File No. 333-269483) under the Securities Act of 1933, as amended (the “Securities Act”), and the rules and regulations (the “Rules and Regulations”) of the Commission thereunder, including a preliminary prospectus relating to the Securities and such amendments to such registration statement (including post effective amendments) as may have been required to be filed prior to or after the date of this Agreement. Such registration statement, as amended (including any post effective amendments), has been declared effective by the Commission. Such registration statement, including amendments thereto (including post effective amendments thereto) and all documents and information deemed to be a part of the Registration Statement through incorporation by reference or otherwise at the time of effectiv
BULLFROG AI HOLDINGS, INC. UNDERWRITING AGREEMENT 1,317,647 Units, Each Consisting of One Share of Common Stock, One Warrant to Purchase One Share of Common Stock, and One Non-tradeable Warrant to Purchase One Share of Common StockUnderwriting Agreement • January 10th, 2023 • BullFrog AI Holdings, Inc. • Pharmaceutical preparations • New York
BULLFROG AI HOLDINGS, INC., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters,” or each, an “Underwriter”), for whom WallachBeth Capital, LLC is acting as Representative (the “Representative”), an aggregate of 1,317,647 Units (the “Firm Units”), each Firm Unit consisting of: (i) one share of the Company’s common stock, $0.00001 par value per share (the “Common Stock”); (ii) one tradeable warrant to purchase one share of Common Stock (the “Firm Tradeable Warrants”); and, one non-tradeable warrant the “Firm Non-tradeable Warrants” and together with the Firm Tradeable Warrants, the “Firm Warrants”). The 1,317,647 shares of Common Stock referred to in this Section are hereinafter referred to as the “Firm Shares” together with the Firm Units and the Firm Warrants, the “Firm Securities.” The Firm Warrants shall be issued pursuant to and shall have the rights
BULLFROG AI HOLDINGS, INC. UNDERWRITING AGREEMENT [*] Units Consisting of [*] Shares of Common Stock, And Warrants to Purchase [*] Shares of Common StockUnderwriting Agreement • October 19th, 2022 • BullFrog AI Holdings, Inc. • Pharmaceutical preparations • New York
BULLFROG AI HOLDINGS, INC., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters,” or each, an “Underwriter”), for whom WallachBeth Capital, LLC is acting as Representative (the “Representative”), an aggregate of [*] Units (the “Firm Units”), each Firm Unit consisting of: (i) one share of the Company’s common stock, $0.00001 par value per share (the “Common Stock”); (ii) one warrant to purchase one share of Common Stock (the “Purchase Warrants”). The [*] shares of Common Stock referred to in this Section are hereinafter referred to as the “Firm Shares” and the Purchase Warrants to purchase [*] shares of Common Stock are hereinafter referred to as the “Firm Warrants,” and together with the Firm Units and the Firm Shares, the “Firm Securities.” The Firm Warrants shall be issued pursuant to and shall have the rights and privileges set forth in, a warrant agen
SCOUTCAM INC. UNDERWRITING AGREEMENT [*] Firm UnitsUnderwriting Agreement • October 19th, 2021 • ScoutCam Inc. • Optical instruments & lenses • New York
ScoutCam Inc., a Nevada corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters,” or each, an “Underwriter”), for whom Aegis Capital Corp. is acting as representative (the “Representative”), an aggregate of [*] units (the “Firm Units”), with each unit consisting of two shares of common stock, par value $0.001 per share (the “Common Stock”) of the Company (the “Firm Shares”), and a Warrant to purchase one share of Common Stock, at an exercise price of $[*] per share and with a term of five (5) years (the “Firm Warrants”). The Company also proposes to sell to the Underwriters, upon the terms and conditions set forth in Section 4 hereof, in the aggregate, up to ___ additional shares of Common Stock representing 15% of the Firm Shares sold in the offering from the Company (the “Option Shares”) and/or up to___ additional Warrants to purchase an aggregate of an additional ___
EX-1.1 7 f11.htm FORM OF UNDERWRITING AGREEMENT UNDERWRITING AGREEMENT ViewTrade Securities, Inc.Underwriting Agreement • May 5th, 2020 • New York
Phio Pharmaceuticals Corp. 993,633 Shares of Common Stock Pre-Funded Warrants to Purchase 1,006,367 Shares of Common Stock and Warrants to Purchase 2,000,000 Shares of Common Stock Underwriting AgreementUnderwriting Agreement • February 13th, 2020 • Phio Pharmaceuticals Corp. • Pharmaceutical preparations • New York
Phio Pharmaceuticals Corp., a company incorporated under the laws of the State of Delaware (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) (i) an aggregate of (a) 993,633 shares of common stock (the “Firm Shares”), par value $0.0001 per share, of the Company (the “Common Stock”) and (b) 1,006,367 pre-funded warrants to purchase 1,006,367 shares of Common Stock at an exercise price of $0.001 per share (the “Pre-Funded Warrants”); and (ii) 2,000,000 warrants to purchase 2,000,000 shares of Common Stock (the “Firm Warrants” and, collectively with the Firm Shares and the Pre-Funded Warrants, the “Firm Securities”). The amount and form of the Firm Securities to be purchased by each Underwriter is set forth opposite its name on Schedule A hereto. The Company also proposes to sell to each Underwriter, at the option of the Underwriter, up to an additional 300,000 shares of Common Stock (the “Option Shares”) and/or warrants to pur
Phio Pharmaceuticals Corp. [________] Shares of Common Stock Pre-Funded Warrants to Purchase [________] Shares of Common Stock and Warrants to Purchase [________] Shares of Common Stock Underwriting AgreementUnderwriting Agreement • January 31st, 2020 • Phio Pharmaceuticals Corp. • Pharmaceutical preparations • New York
Phio Pharmaceuticals Corp., a company incorporated under the laws of the State of Delaware (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) (i) an aggregate of (a) [________] shares of common stock (the “Firm Shares”), par value $0.0001 per share, of the Company (the “Common Stock”) and (b) [________] pre-funded warrants to purchase [________] shares of Common Stock at an exercise price of $0.001 per share (the “Pre-Funded Warrants”); and (ii) [________] warrants to purchase [________] shares of Common Stock (the “Firm Warrants” and, collectively with the Firm Shares and the Pre-Funded Warrants, the “Firm Securities”). The amount and form of the Firm Securities to be purchased by each Underwriter is set forth opposite its name on Schedule A hereto. The Company also proposes to sell to each Underwriter, at the option of the Underwriter, up to an additional [________] shares of Common Stock (the “Option Shares”) and/or warra
OpGen, Inc. 2,590,170 Shares of Common Stock Pre-Funded Warrants to Purchase 2,109,830 Shares of Common Stock and Warrants to Purchase 4,700,000 Shares of Common Stock Underwriting AgreementUnderwriting Agreement • October 28th, 2019 • Opgen Inc • Services-medical laboratories • New York
OpGen, Inc., a company incorporated under the laws of the State of Delaware (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) (i) an aggregate of (a) 2,590,170 shares of common stock (the “Firm Shares”), par value $0.01 per share, of the Company (the “Common Stock”) and (b) 2,109,830 pre-funded warrants to purchase 2,109,830 shares of Common Stock at an exercise price of $0.01 per share (the “Pre-Funded Warrants”); and (ii) warrants to purchase 4,700,000 shares of Common Stock (the “Firm Warrants” and, collectively with the Firm Shares and the Pre-Funded Warrants, the “Firm Securities”). The amount and form of the Firm Securities to be purchased by each Underwriter is set forth opposite its name on Schedule A hereto. The Company also proposes to sell to each Underwriter, at the option of the Underwriter, up to an additional 705,000 shares of Common Stock (the “Option Shares”) and/or warrants to purchase up to an aggregate o
OpGen, Inc. [●] Shares of Common Stock Pre-Funded Warrants to Purchase [●] Shares of Common Stock and Warrants to Purchase [●] Shares of Common Stock Underwriting AgreementUnderwriting Agreement • October 15th, 2019 • Opgen Inc • Services-medical laboratories • New York
OpGen, Inc., a company incorporated under the laws of the State of Delaware (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) (i) an aggregate of (a) [●] shares of common stock (the “Firm Shares”), par value $0.01 per share, of the Company (the “Common Stock”) and (b) [●] pre-funded warrants to purchase [●] shares of Common Stock at an exercise price of $0.01 per share (the “Pre-Funded Warrants”); and (ii) warrants to purchase [●] shares of Common Stock (the “Firm Warrants” and, collectively with the Firm Shares and the Pre-Funded Warrants, the “Firm Securities”). The amount and form of the Firm Securities to be purchased by each Underwriter is set forth opposite its name on Schedule A hereto. The Company also proposes to sell to each Underwriter, at the option of the Underwriter, up to an additional [●] shares of Common Stock (the “Option Shares”) and/or warrants to purchase up to an aggregate of [●] shares of Common Stock
UNDERWRITING AGREEMENTUnderwriting Agreement • March 9th, 2018 • Golden Bull LTD • Finance services • New York
The undersigned, Golden Bull Limited, a company limited by shares organized under the laws of the Cayman Islands (the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, for whom ViewTrade Securities, Inc. is acting as representative (in such capacity, the “Representative,” if there are no underwriters other than the Representative, reference to multiple underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as underwriter, the “Underwriters” and each an “Underwriter”) to issue and sell to the Underwriters an aggregate of 1,550,000 ordinary shares, $0.01 par value per share (“Ordinary shares”), of the Company (the “Firm Shares”). The Company has also granted to the several Underwriters an option to purchase up to 232,500 additional Ordinary shares, on the terms and for the purposes set forth in Section 1(b) hereof (the “Option Shares”). The Firm Shares and any Option Shares purc
UNDERWRITING AGREEMENTUnderwriting Agreement • December 22nd, 2017 • Golden Bull LTD • Finance services • New York
The undersigned, Golden Bull Limited, a company limited by shares organized under the laws of the Cayman Islands (the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, for whom ViewTrade Securities, Inc. is acting as representative (in such capacity, the “Representative,” if there are no underwriters other than the Representative, reference to multiple underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as underwriter, the “Underwriters” and each an “Underwriter”) to issue and sell to the Underwriters an aggregate of 2,000,000 ordinary shares, $0.01 par value per share (“Ordinary shares”), of the Company (the “Firm Shares”). The Company has also granted to the several Underwriters an option to purchase up to 300,000 additional Ordinary shares, on the terms and for the purposes set forth in Section 1(b) hereof (the “Option Shares”). The Firm Shares and any Option Shares purc
UNDERWRITING AGREEMENTUnderwriting Agreement • June 2nd, 2017 • Newater Technology, Inc. • Sanitary services • New York
The undersigned, Newater Technology, Inc., a company limited by shares organized under the laws of the British Virgin Islands (the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, for whom ViewTrade Securities, Inc. is acting as representative (in such capacity, the “Representative,” if there are no underwriters other than the Representative, reference to multiple underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as underwriter, the “Underwriters” and each an “Underwriter”) to issue and sell to the Underwriters an aggregate of 1,400,000 common shares, $0.001 par value per share (“Common Shares”), of the Company (the “Firm Shares”). The Company has also granted to the several Underwriters an option to purchase up to 210,000 additional Common Shares, on the terms and for the purposes set forth in Section 2 hereof (the “Option Shares”). The Firm Shares and any Option Shares
